Enhancing the efficacy of glycolytic blockade in cancer cells via RAD51 inhibition

Genetic and Small Molecule Disruption of the AID/RAD51 Axis Similarly Protects Nonobese Diabetic Mice from Type 1 Diabetes through Expansion of Regulatory B Lymphocytes

(2017) Jeremy J. Ratiu et al.   JOURNAL OF IMMUNOLOGY

Intratumor Heterogeneity in Primary Kidney Cancer Revealed by Metabolic Profiling of Multiple Spatially Separated Samples within Tumors

(2017) Takatsugu Okegawa et al.   EBioMedicine

Involvement of activation-induced cytidine deaminase in skin cancer development

(2016) Taichiro Nonaka et al.   JOURNAL OF CLINICAL INVESTIGATION

Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous Carcinogenesis

(2016) Stav Sapoznik et al.   NEOPLASIA

IL-21–Driven Neoplasms in SJL Mice Mimic Some Key Features of Human Angioimmunoblastic T-Cell Lymphoma

(2015) Shweta Jain et al.   AMERICAN JOURNAL OF PATHOLOGY

Activation-Induced Cytidine Deaminase Contributes to Pancreatic Tumorigenesis by Inducing Tumor-Related Gene Mutations

(2015) Y. Sawai et al.   CANCER RESEARCH

Hepatic inflammation facilitates transcription-associated mutagenesis via AID activity and enhances liver tumorigenesis

(2015) Tomonori Matsumoto et al.   CARCINOGENESIS

2-Deoxyglucose Induces Cell Cycle Arrest and Apoptosisin Colorectal Cancer Cells Independent of Its Glycolysis Inhibition

(2015) Pratik Muley et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy

(2014) Dongsheng Zhang et al.   CANCER LETTERS

IgH Chain Class Switch Recombination: Mechanism and Regulation

(2014) Janet Stavnezer et al.   JOURNAL OF IMMUNOLOGY

Molecular aspects of cancer cell resistance to chemotherapy

(2013) Magali Rebucci et al.   BIOCHEMICAL PHARMACOLOGY

Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models

(2013) D. Siolas et al.   CANCER RESEARCH

Attenuating homologous recombination stimulates an AID-induced antileukemic effect

(2013) Kristin R. Lamont et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis

(2012) Takahiro Shimizu et al.   CANCER SCIENCE

The role of activation-induced cytidine deaminase in lymphomagenesis

(2012) Xiwen Gu et al.   CURRENT OPINION IN HEMATOLOGY

Activation-Induced Cytidine Deaminase-Initiated Off-Target DNA Breaks Are Detected and Resolved during S Phase

(2012) M. G. Hasham et al.   JOURNAL OF IMMUNOLOGY

MHC Class I Family Proteins Retard Systemic Lupus Erythematosus Autoimmunity and B Cell Lymphomagenesis

(2011) C. G. McPhee et al.   JOURNAL OF IMMUNOLOGY

Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination

(2010) Muneer G Hasham et al.   NATURE IMMUNOLOGY

The Glycolytic Inhibitor 2-Deoxyglucose Activates Multiple Prosurvival Pathways through IGF1R

(2009) Diansheng Zhong et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

AID Produces DNA Double-Strand Breaks in Non-Ig Genes and Mature B Cell Lymphomas with Reciprocal Chromosome Translocations

(2009) Davide F. Robbiani et al.   MOLECULAR CELL

Replication fork reversal and the maintenance of genome stability

(2009) J. Atkinson et al.   NUCLEIC ACIDS RESEARCH

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE

Homologous Recombination Is Necessary for Normal Lymphocyte Development

(2008) L. B. Caddle et al.   MOLECULAR AND CELLULAR BIOLOGY

Two levels of protection for the B cell genome during somatic hypermutation

(2008) Man Liu et al.   NATURE

A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth

(2008) M. Ralser et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA